Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Onterris, Inc.MEG · Entity 5360 | Director | January 01, 2026 | January 06, 2026 |
| PURE BIOSCIENCE, INC.PURE · Entity 7969 | Director | February 26, 2018 | March 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Onterris, Inc.
Report date January 01, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,288 |
Reported balance
After 2026-01-01 transaction · row 1
1 source rowRow 1 · 2026-01-01 · Grant · Acquired 4,430 · Balance 28,288 |
PURE BIOSCIENCE, INC.
Report date February 26, 2018 · Filed March 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.78 · Expires 2023-02-27 | Direct | 100,000 |
Reported balance
After 2018-02-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-02-26 · Grant · Acquired 100,000 · Balance 100,000 F1: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2026 Filed Jan 6, 2026 18:30 UTC | Onterris, Inc. MEG · Entity 5360 | GrantCommon Stock | 4,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004911 · ownership.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,288 Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:19 UTC | Onterris, Inc. MEG · Entity 5360 | GrantCommon Stock | 5,929 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-001560 · ownership.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,858 Read SEC document |
| January 01, 2024 Filed Jan 2, 2024 21:22 UTC | Onterris, Inc. MEG · Entity 5360 | GrantCommon Stock | 3,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-000266 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,929 Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 17:56 UTC | Onterris, Inc. MEG · Entity 5360 | PurchaseCommon Stock | 500 | $25.26 | $12,627.50 |
DisclosureSEC source: 0001209191-23-055058 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,506 Read SEC document |
| May 12, 2023 Filed May 16, 2023 16:54 UTC | Onterris, Inc. MEG · Entity 5360 | PurchaseCommon Stock | 1,000 | $36.05 | $36,050.00 |
DisclosureSEC source: 0001209191-23-029836 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,006 Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 18:00 UTC | Onterris, Inc. MEG · Entity 5360 | PurchaseCommon Stock | 1,000 | $36.61 | $36,610.00 |
DisclosureSEC source: 0001209191-23-016924 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,006 F1 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the Issuer were purchased in multiple transactions by the Reporting Person at prices ranging from $36.56 to $36.61, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares of common stock acquired at each separate price within the range. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 18:00 UTC | Onterris, Inc. MEG · Entity 5360 | GrantCommon Stock | 2,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000379 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,006 Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 18:19 UTC | Onterris, Inc. MEG · Entity 5360 | GrantCommon Stock | 1,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000325 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,528 Read SEC document |
| December 13, 2021 Filed Dec 13, 2021 18:45 UTC | Onterris, Inc. MEG · Entity 5360 | PurchaseCommon Stock | 863 | $69.50 | $59,978.50 |
DisclosureSEC source: 0001209191-21-069322 · doc4.xml · nonDerivative · entry 3 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,968 F2 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the Issuer were purchased in multiple transactions by the Reporting Person at prices ranging from $69.49 to $69.50, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares of common stock acquired at each separate price within the range. Read SEC document |
| December 13, 2021 Filed Dec 13, 2021 18:45 UTC | Onterris, Inc. MEG · Entity 5360 | PurchaseCommon Stock | 6,337 | $68.62 | $434,844.94 |
DisclosureSEC source: 0001209191-21-069322 · doc4.xml · nonDerivative · entry 2 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,105 F1 · price: The price reported in Column 4 is a weighted average price. These shares of common stock of the Issuer were purchased in multiple transactions by the Reporting Person at prices ranging from $68.24 to $69.16, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares of common stock acquired at each separate price within the range. Read SEC document |
| December 13, 2021 Filed Dec 13, 2021 18:45 UTC | Onterris, Inc. MEG · Entity 5360 | PurchaseCommon Stock | 75 | $67.09 | $5,031.75 |
DisclosureSEC source: 0001209191-21-069322 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 768 Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 16:29 UTC | Onterris, Inc. MEG · Entity 5360 | GrantCommon Stock | 243 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-040962 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 693 Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:14 UTC | PURE BIOSCIENCE, INC. PURE · Entity 7969 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.78 | $0.00 |
DisclosureSEC source: 0001209191-18-014692 · doc4.xml · derivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2023-02-27 F1 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 23:19 UTC | PURE BIOSCIENCE, INC. PURE · Entity 7969 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001209191-17-050214 · doc4.xml · derivative · entry 2 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-08-23 F2 · derivative.exercise_date: The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 23:19 UTC | PURE BIOSCIENCE, INC. PURE · Entity 7969 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-050214 · doc4.xml · nonDerivative · entry 1 Field Janet Risi · CIK 0001713140 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,140 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2018 or January 15, 2018 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.